The rate of chronic kidney disease progression in advanced stages and the dynamics of the uremic syndrome parameters

D. Sadovskaya, K. A. Vishnevsky, I. N. Konakova, N. Bakulina
{"title":"The rate of chronic kidney disease progression in advanced stages and the dynamics of the uremic syndrome parameters","authors":"D. Sadovskaya, K. A. Vishnevsky, I. N. Konakova, N. Bakulina","doi":"10.36485/1561-6274-2022-26-4-50-65","DOIUrl":null,"url":null,"abstract":"Background. The current practice of patients with advanced CKD stages management is not optimal, as it leads to the risk of an emergency dialysis start with an unfavorable prognosis, does not utilize all the possibilities of nephroprotective therapy and does not provide optimal correction of the most important uremic syndromes before starting dialysis, which worsens the per spectives of long-term patient-oriented dialysis treatment. THE AIM. The obtained features of the standard practice will provide the possibility to assemble group carefully matched with intensive management group to compare outcomes in future prospective study and to assess the significance of the proposed program components of the intensive management of patients with advanced stages of chronic kidney disease in the \"transition center\". PATIENTS AND METHODS. A group with regular (at least 6 visits per year) follow-up of 540 patients with baseline CKD3B was retrospectively formed from the city nephrology center database (which included 7696 patients with CKD3 and higher) and was traced to the need for renal replacement therapy or to death. As part of the follow-up, patients underwent regular clinical and laboratory evaluation and received nephroprotective therapy, which were recorded in the database. RESULTS. The dynamics of an accelerating decrease in eGFR (according to CKD-EPICr) from median of -2.76 (-3.26÷-2.36) to -4.34 (-5.01÷-3.46) and further to -6.01 (-7.11÷-5.23) ml/min/1.73 m2/ year for the stages of CKD3B→CKD4→CKD5 in parallel with the dynamics of blood levels of hemoglobin (and iron), phosphate (and calcium), albumin, as well as proteinuria is described – factors that turned out to be significant in the multiple regression model with a dependent variable – the rate of eGFR reduction (the significance of the model F=2.864; p=0.015). CONCLUSION. The obtained detailed description of the progression of CKD in a typical regional population under standard management conditions will provide the possiblity to form a group from a cohort of regular monitoring in a nephrocenter, carefully compared with an intensive management group in the prototype of a transition center based on a large inpatient dialysis center to assess the significance of the components of the proposed control and interventions program.","PeriodicalId":19089,"journal":{"name":"Nephrology (Saint-Petersburg)","volume":"64 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology (Saint-Petersburg)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36485/1561-6274-2022-26-4-50-65","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background. The current practice of patients with advanced CKD stages management is not optimal, as it leads to the risk of an emergency dialysis start with an unfavorable prognosis, does not utilize all the possibilities of nephroprotective therapy and does not provide optimal correction of the most important uremic syndromes before starting dialysis, which worsens the per spectives of long-term patient-oriented dialysis treatment. THE AIM. The obtained features of the standard practice will provide the possibility to assemble group carefully matched with intensive management group to compare outcomes in future prospective study and to assess the significance of the proposed program components of the intensive management of patients with advanced stages of chronic kidney disease in the "transition center". PATIENTS AND METHODS. A group with regular (at least 6 visits per year) follow-up of 540 patients with baseline CKD3B was retrospectively formed from the city nephrology center database (which included 7696 patients with CKD3 and higher) and was traced to the need for renal replacement therapy or to death. As part of the follow-up, patients underwent regular clinical and laboratory evaluation and received nephroprotective therapy, which were recorded in the database. RESULTS. The dynamics of an accelerating decrease in eGFR (according to CKD-EPICr) from median of -2.76 (-3.26÷-2.36) to -4.34 (-5.01÷-3.46) and further to -6.01 (-7.11÷-5.23) ml/min/1.73 m2/ year for the stages of CKD3B→CKD4→CKD5 in parallel with the dynamics of blood levels of hemoglobin (and iron), phosphate (and calcium), albumin, as well as proteinuria is described – factors that turned out to be significant in the multiple regression model with a dependent variable – the rate of eGFR reduction (the significance of the model F=2.864; p=0.015). CONCLUSION. The obtained detailed description of the progression of CKD in a typical regional population under standard management conditions will provide the possiblity to form a group from a cohort of regular monitoring in a nephrocenter, carefully compared with an intensive management group in the prototype of a transition center based on a large inpatient dialysis center to assess the significance of the components of the proposed control and interventions program.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性肾脏疾病晚期进展率和尿毒症综合征参数的动态变化
背景。目前对晚期CKD患者的管理并不理想,因为它会导致紧急透析开始的风险和不良预后,没有利用肾保护治疗的所有可能性,也没有在开始透析前提供最重要的尿毒症综合征的最佳纠正,这使长期以患者为导向的透析治疗的前景恶化。的目标。所获得的标准实践的特征将提供可能性,将组与强化管理组仔细匹配,以比较未来前瞻性研究的结果,并评估在“过渡中心”对晚期慢性肾脏疾病患者进行强化管理的拟议方案组成部分的意义。患者和方法。对540例基线CKD3B患者(包括7696例CKD3及以上患者)进行定期(每年至少6次)随访的一组回顾性研究,追踪到需要肾脏替代治疗或死亡。作为随访的一部分,患者接受了定期的临床和实验室评估,并接受了肾保护治疗,这些都被记录在数据库中。结果。在CKD3B→CKD4→CKD5阶段,eGFR加速下降的动态(根据CKD-EPICr)从中位数-2.76 (-3.26÷-2.36)到-4.34 (-5.01÷-3.46),并进一步到-6.01 (-7.11÷-5.23) ml/min/1.73 m2/年,与血液中血红蛋白(和铁)、磷酸盐(和钙)、白蛋白、以及蛋白尿——在具有因变量的多重回归模型中被证明是显著的因素——eGFR降低率(模型显著性F=2.864;p = 0.015)。结论。在标准管理条件下获得的典型区域人群CKD进展的详细描述将提供从肾中心定期监测队列中形成一个组的可能性,并与基于大型住院透析中心的过渡中心原型中的强化管理组进行仔细比较,以评估所提议的控制和干预计划组成部分的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
0
期刊最新文献
The concentration of P-selectin in the blood serum of patients with chronic kidney disease Nutritional disorders and survival rate of elderly and geriatric patients with CKD 3B-5 stage Clinical signifi cance of various variants of euthyroid pathology syndrome in patients with end-stage chronic kidney disease on programmed hemodialysis Features of the course of the new coronavirus infection COVID-19 in patients with chronic kidney disease Role of urinary tract microbiota and urine proteome in urolithiasis pathogenesis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1